Published in Bipolar Disord on October 01, 2015
A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem (1957) 173.99
A rating scale for depression. J Neurol Neurosurg Psychiatry (1960) 90.89
The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry (1998) 65.11
What's wrong with Bonferroni adjustments. BMJ (1998) 19.89
Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication. Arch Gen Psychiatry (2007) 8.11
Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial. Arch Gen Psychiatry (1999) 5.40
Changes in consumption of omega-3 and omega-6 fatty acids in the United States during the 20th century. Am J Clin Nutr (2011) 4.03
Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial. Lancet (2010) 3.72
Resolvin E1, an endogenous lipid mediator derived from omega-3 eicosapentaenoic acid, protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis. Proc Natl Acad Sci U S A (2005) 3.32
Does the brain noradrenaline network mediate the effects of the CO2 challenge? J Psychopharmacol (2003) 2.81
Updated systematic review and meta-analysis of the effects of n-3 long-chain polyunsaturated fatty acids on depressed mood. Am J Clin Nutr (2010) 2.54
Efficacy of ethyl-eicosapentaenoic acid in bipolar depression: randomised double-blind placebo-controlled study. Br J Psychiatry (2006) 2.00
Reduced brain inositol in lithium-treated rats. Nat New Biol (1971) 1.97
The International Society for Bipolar Disorders (ISBD) Task Force report on the nomenclature of course and outcome in bipolar disorders. Bipolar Disord (2009) 1.91
Distribution and fatty acid composition of phosphoglycerides in normal human brain. J Lipid Res (1968) 1.83
Genetics of bipolar disorder. Lancet (2013) 1.82
Meta-analysis of the effects of eicosapentaenoic acid (EPA) in clinical trials in depression. J Clin Psychiatry (2011) 1.81
Fatty acid composition of brain, retina, and erythrocytes in breast- and formula-fed infants. Am J Clin Nutr (1994) 1.77
Targeted alteration of dietary n-3 and n-6 fatty acids for the treatment of chronic headaches: a randomized trial. Pain (2013) 1.69
EPA but not DHA appears to be responsible for the efficacy of omega-3 long chain polyunsaturated fatty acid supplementation in depression: evidence from a meta-analysis of randomized controlled trials. J Am Coll Nutr (2009) 1.63
Omega-3 eicosapentaenoic acid in bipolar depression: report of a small open-label study. J Clin Psychiatry (2005) 1.54
A quantitative method for measuring regional in vivo fatty-acid incorporation into and turnover within brain phospholipids: review and critical analysis. Brain Res Brain Res Rev (1993) 1.51
Omega-3 fatty acids as treatments for mental illness: which disorder and which fatty acid? Lipids Health Dis (2007) 1.51
Half-lives of docosahexaenoic acid in rat brain phospholipids are prolonged by 15 weeks of nutritional deprivation of n-3 polyunsaturated fatty acids. J Neurochem (2004) 1.42
The Clinician-Administered Rating Scale for Mania (CARS-M): development, reliability, and validity. Biol Psychiatry (1994) 1.33
Cross-national comparisons of seafood consumption and rates of bipolar disorders. Am J Psychiatry (2003) 1.33
Role of omega-3 fatty acids in the treatment of depressive disorders: a comprehensive meta-analysis of randomized clinical trials. PLoS One (2014) 1.32
Bipolar disorder and mechanisms of action of mood stabilizers. Brain Res Rev (2009) 1.31
Do lithium and anticonvulsants target the brain arachidonic acid cascade in bipolar disorder? Arch Gen Psychiatry (2002) 1.24
Selective deficits in erythrocyte docosahexaenoic acid composition in adult patients with bipolar disorder and major depressive disorder. J Affect Disord (2010) 1.23
Medical comorbidity in bipolar disorder: implications for functional outcomes and health service utilization. Psychiatr Serv (2006) 1.17
Formation of highly reactive cyclopentenone isoprostane compounds (A3/J3-isoprostanes) in vivo from eicosapentaenoic acid. J Biol Chem (2008) 1.15
Altered arachidonic acid cascade enzymes in postmortem brain from bipolar disorder patients. Mol Psychiatry (2009) 1.14
Upregulated liver conversion of alpha-linolenic acid to docosahexaenoic acid in rats on a 15 week n-3 PUFA-deficient diet. J Lipid Res (2006) 1.13
The prevalence and impact of migraine headache in bipolar disorder: results from the Canadian Community Health Survey. Headache (2006) 1.13
Double-blind, randomized, placebo-controlled trials of ethyl-eicosapentanoate in the treatment of bipolar depression and rapid cycling bipolar disorder. Biol Psychiatry (2006) 1.13
Omega-3 fatty acid monotherapy for pediatric bipolar disorder: a prospective open-label trial. Eur Neuropsychopharmacol (2007) 1.12
Eicosapentaenoic acid appears to be the key omega-3 fatty acid component associated with efficacy in major depressive disorder: a critique of Bloch and Hannestad and updated meta-analysis. Mol Psychiatry (2012) 1.11
Bipolar II disorder: arguments for and against a distinct diagnostic entity. Bipolar Disord (2008) 1.11
Diagnostic guidelines for bipolar disorder: a summary of the International Society for Bipolar Disorders Diagnostic Guidelines Task Force Report. Bipolar Disord (2008) 1.11
Lowering dietary linoleic acid reduces bioactive oxidized linoleic acid metabolites in humans. Prostaglandins Leukot Essent Fatty Acids (2012) 1.09
Polyunsaturated fatty acid deficit in patients with bipolar mania. Eur Neuropsychopharmacol (2003) 1.05
No evidence for direct incorporation of esterified palmitic acid from plasma into brain lipids of awake adult rat. J Lipid Res (1997) 1.05
Brain arachidonic and docosahexaenoic acid cascades are selectively altered by drugs, diet and disease. Prostaglandins Leukot Essent Fatty Acids (2008) 1.05
Reduced mania and depression in juvenile bipolar disorder associated with long-chain omega-3 polyunsaturated fatty acid supplementation. Eur J Clin Nutr (2009) 1.04
Eicosapentaenoic acid (EPA) induces Ca(2+)-independent activation and translocation of endothelial nitric oxide synthase and endothelium-dependent vasorelaxation. FEBS Lett (2001) 1.04
Omega-3 for bipolar disorder: meta-analyses of use in mania and bipolar depression. J Clin Psychiatry (2011) 1.02
Are omega-3 fatty acids antidepressants or just mood-improving agents? The effect depends upon diagnosis, supplement preparation, and severity of depression. Mol Psychiatry (2012) 1.00
The "switch process" in manic-depressive illness. II. Relationship to catecholamines, REM sleep, and drugs. Arch Gen Psychiatry (1972) 1.00
The prevalence of migraine in patients with bipolar and unipolar affective disorders. Cephalalgia (2001) 1.00
Dietary n-6 PUFA deprivation for 15 weeks reduces arachidonic acid concentrations while increasing n-3 PUFA concentrations in organs of post-weaning male rats. Biochim Biophys Acta (2008) 0.99
The pathophysiology of migraine: year 2005. J Headache Pain (2005) 0.98
The trigemino-vascular system and migraine. Pathol Biol (Paris) (1992) 0.98
Diffusion of docosahexaenoic and eicosapentaenoic acids through the blood-brain barrier: An in situ cerebral perfusion study. Neurochem Int (2009) 0.98
Differential effects of antipsychotic medications on polyunsaturated fatty acid biosynthesis in rats: Relationship with liver delta6-desaturase expression. Schizophr Res (2011) 0.98
Clinical characteristics of patients with major affective disorders and comorbid migraine. World J Biol Psychiatry (2001) 0.97
Plasma free polyunsaturated fatty acid levels are associated with symptom severity in acute mania. Bipolar Disord (2007) 0.96
Novel chemical mediators in the resolution of inflammation: resolvins and protectins. Anesthesiol Clin (2006) 0.95
Fatty acid uptake and incorporation in brain: studies with the perfusion model. J Mol Neurosci (2001) 0.95
Cross-prevalence of migraine and bipolar disorder. Bipolar Disord (2010) 0.93
Low-n-6 and low-n-6 plus high-n-3 diets for use in clinical research. Br J Nutr (2013) 0.93
Is a family history of bipolar disorder a risk factor for migraine among affectively ill patients? Psychopathology (2009) 0.93
Low omega-6 vs. low omega-6 plus high omega-3 dietary intervention for chronic daily headache: protocol for a randomized clinical trial. Trials (2011) 0.92
Elevated PLA2 activity in schizophrenics and other psychiatric patients. Biol Psychiatry (1993) 0.92
Validation of a food frequency questionnaire to assess intake of n-3 polyunsaturated fatty acids in subjects with and without major depressive disorder. J Am Diet Assoc (2011) 0.91
Omega-3 fatty acids and perinatal depression: a review of the literature and recommendations for future research. Prostaglandins Leukot Essent Fatty Acids (2006) 0.90
Dietary intake and plasma metabolomic analysis of polyunsaturated fatty acids in bipolar subjects reveal dysregulation of linoleic acid metabolism. J Psychiatr Res (2014) 0.89
Preliminary in vivo evidence of increased N-acetyl-aspartate following eicosapentanoic acid treatment in patients with bipolar disorder. J Psychopharmacol (2006) 0.89
Prostaglandin E(2) induces immediate migraine-like attack in migraine patients without aura. Cephalalgia (2012) 0.89
Valproate (valproic acid or sodium valproate or a combination of the two) for the prophylaxis of episodic migraine in adults. Cochrane Database Syst Rev (2013) 0.89
Randomized, placebo-controlled trial of flax oil in pediatric bipolar disorder. Bipolar Disord (2010) 0.88
Protective effect of eicosapentaenoic acid on palmitate-induced apoptosis in neonatal cardiomyocytes. Biochim Biophys Acta (2008) 0.88
Greater number of capillary endothelial cell mitochondria in brain than in muscle. Proc Soc Exp Biol Med (1975) 0.88
Migraine life-time prevalence in mental disorders: concurrent comparisons with first-degree relatives and the general population. Invest Clin (2012) 0.87
Toward clinically applicable biomarkers in bipolar disorder: focus on BDNF, inflammatory markers, and endothelial function. Curr Psychiatry Rep (2013) 0.86
Panic comorbidity with bipolar disorder: what is the manic-panic connection? Bipolar Disord (2006) 0.86
Fats and factors: lipid profiles associate with personality factors and suicidal history in bipolar subjects. PLoS One (2012) 0.86
Dietary omega-6 fatty acid lowering increases bioavailability of omega-3 polyunsaturated fatty acids in human plasma lipid pools. Prostaglandins Leukot Essent Fatty Acids (2014) 0.85
Gender differences, clinical correlates, and longitudinal outcome of bipolar disorder with comorbid migraine. J Clin Psychiatry (2014) 0.85
Are disturbances in lipid-protein interactions by phospholipase-A2 a predisposing factor in affective illness? Biol Psychiatry (1989) 0.84
Specific distribution of short-chain fatty acids in molecular distillates of bovine milk fat. J Lipid Res (1968) 0.84
Urinary catecholamines and plasma hormones predict mood state in rapid cycling bipolar affective disorder. J Affect Disord (1995) 0.83
Lithium and the other mood stabilizers effective in bipolar disorder target the rat brain arachidonic acid cascade. ACS Chem Neurosci (2014) 0.83
Association of plasma ω-3 and ω-6 lipids with burden of disease measures in bipolar subjects. J Psychiatr Res (2012) 0.82
Functional modulation of mitochondria by eicosapentaenoic acid provides protection against ceramide toxicity to C6 glioma cells. J Agric Food Chem (2009) 0.82
The saturated fatty acid, palmitic acid, induces anxiety-like behavior in mice. Metabolism (2014) 0.81
Omega-3 fatty acids decreased irritability of patients with bipolar disorder in an add-on, open label study. Nutr J (2005) 0.81
Omega-3 fatty acid treatment, with or without cytidine, fails to show therapeutic properties in bipolar disorder: a double-blind, randomized add-on clinical trial. J Clin Psychopharmacol (2012) 0.80
Omega-3 fatty acids are more beneficial in the depressive phase than in the manic phase in patients with bipolar I disorder. J Clin Psychiatry (2005) 0.80
Fasting Induces IL-1 Resistance and Free-Fatty Acid-Mediated Up-Regulation of IL-1R2 and IL-1RA. Front Immunol (2014) 0.80
Mutational analysis of phospholipase A2A: a positional candidate susceptibility gene for bipolar disorder. Mol Psychiatry (1999) 0.79
Serum calcium-independent phospholipase A2 activity in bipolar affective disorder. Bipolar Disord (2006) 0.79
Polyunsaturated fatty acids induce tight junctions to form in brain capillary endothelial cells. Neuroscience (2003) 0.79
Migraine general aspects. Handb Clin Neurol (2010) 0.79
Kinetics of eicosapentaenoic acid in brain, heart and liver of conscious rats fed a high n-3 PUFA containing diet. Prostaglandins Leukot Essent Fatty Acids (2013) 0.78
Plasma levels of n-3 fatty acids in bipolar patients: deficit restricted to DHA. J Psychiatr Res (2012) 0.78
Allelic association study between phospholipase A2 genes and bipolar affective disorder. Bipolar Disord (2003) 0.78
Genetic association between alleles of pancreatic phospholipase A2 gene and bipolar affective disorder. Psychiatr Genet (1995) 0.78
Association between polymorphisms in phospholipase A2 genes and the plasma triglyceride response to an n-3 PUFA supplementation: a clinical trial. Lipids Health Dis (2015) 0.77
Reduced activities of phospholipases A2 in platelets of drug-naïve bipolar disorder patients. Bipolar Disord (2014) 0.77
Pathways of polyunsaturated fatty acid utilization: implications for brain function in neuropsychiatric health and disease. Brain Res (2014) 0.94
Transient postnatal fluoxetine leads to decreased brain arachidonic acid metabolism and cytochrome P450 4A in adult mice. Prostaglandins Leukot Essent Fatty Acids (2014) 0.77